Literature DB >> 24559452

Hox gene dysregulation in acute myeloid leukemia.

Etienne De Braekeleer1, Nathalie Douet-Guilbert, Audrey Basinko, Marie-Josée Le Bris, Frédéric Morel, Marc De Braekeleer.   

Abstract

In humans, class I homeobox genes (HOX genes) are distributed in four clusters. Upstream regulators include transcriptional activators and members of the CDX family of transcription factors. HOX genes encode proteins and need cofactor interactions, to increase their specificity and selectivity. HOX genes contribute to the organization and regulation of hematopoiesis by controlling the balance between proliferation and differentiation. Changes in HOX gene expression can be associated with chromosomal rearrangements generating fusion genes, such as those involving MLL and NUP98, or molecular defects, such as mutations in NPM1 and CEBPA for example. Several miRNAs are involved in the control of HOX gene expression and their expression correlates with HOX gene dysregulation. HOX genes dysregulation is a dominant mechanism of leukemic transformation. A better knowledge of their target genes and the mechanisms by which their dysregulated expression contributes to leukemogenesis could lead to the development of new drugs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24559452     DOI: 10.2217/fon.13.195

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  14 in total

1.  A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes.

Authors:  Chi-Yuan Yao; Ching-Hsuan Chen; Huai-Hsuan Huang; Hsin-An Hou; Chien-Chin Lin; Mei-Hsuan Tseng; Chein-Jun Kao; Tzu-Pin Lu; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Blood Adv       Date:  2017-08-16

2.  Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells.

Authors:  D H Spencer; M A Young; T L Lamprecht; N M Helton; R Fulton; M O'Laughlin; C Fronick; V Magrini; R T Demeter; C A Miller; J M Klco; R K Wilson; T J Ley
Journal:  Leukemia       Date:  2015-01-20       Impact factor: 11.528

3.  MLL::AF9 degradation induces rapid changes in transcriptional elongation and subsequent loss of an active chromatin landscape.

Authors:  Sarah Naomi Olsen; Laura Godfrey; James P Healy; Yoolim A Choi; Yan Kai; Charles Hatton; Florian Perner; Elena L Haarer; Behnam Nabet; Guo-Cheng Yuan; Scott A Armstrong
Journal:  Mol Cell       Date:  2022-03-03       Impact factor: 19.328

Review 4.  Deregulation of the HOXA9/MEIS1 axis in acute leukemia.

Authors:  Cailin T Collins; Jay L Hess
Journal:  Curr Opin Hematol       Date:  2016-07       Impact factor: 3.284

5.  Higher expression levels of the HOXA9 gene, closely associated with MLL-PTD and EZH2 mutations, predict inferior outcome in acute myeloid leukemia.

Authors:  Li Gao; Junzhong Sun; Fang Liu; Hui Zhang; Yigai Ma
Journal:  Onco Targets Ther       Date:  2016-02-09       Impact factor: 4.147

6.  The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.

Authors:  Marina Díaz-Beyá; Salut Brunet; Josep Nomdedéu; Marta Pratcorona; Anna Cordeiro; David Gallardo; Lourdes Escoda; Mar Tormo; Inmaculada Heras; Josep Maria Ribera; Rafael Duarte; María Paz Queipo de Llano; Joan Bargay; Antonia Sampol; Meritxell Nomdedeu; Ruth M Risueño; Montserrat Hoyos; Jorge Sierra; Mariano Monzo; Alfons Navarro; Jordi Esteve
Journal:  Oncotarget       Date:  2015-10-13

7.  Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.

Authors:  Hongmei Luo; Yu Qin; Frederic Reu; Sujuan Ye; Yang Dai; Jingcao Huang; Fangfang Wang; Dan Zhang; Ling Pan; Huanling Zhu; Yu Wu; Ting Niu; Zhijian Xiao; Yuhuan Zheng; Ting Liu
Journal:  J Hematol Oncol       Date:  2016-11-17       Impact factor: 17.388

8.  Long noncoding RNA HOTAIRM1 promotes myeloid-derived suppressor cell expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.

Authors:  Jinyu Zhang; Bal Krishna Chand Thakuri; Juan Zhao; Lam N Nguyen; Lam N T Nguyen; Dechao Cao; Xindi Dang; Sushant Khanal; Madison Schank; Zeyuan Lu; Xiao Y Wu; Zheng D Morrison; Mohamed El Gazzar; Zhengke Li; Yong Jiang; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.632

9.  Effect of silencing HOXA5 gene expression using RNA interference on cell cycle and apoptosis in Jurkat cells.

Authors:  Hui-Ping Huang; Wen-Jun Liu; Qu-Lian Guo; Yong-Qi Bai
Journal:  Int J Mol Med       Date:  2016-02-04       Impact factor: 4.101

10.  A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways.

Authors:  Indre Piragyte; Thomas Clapes; Aikaterini Polyzou; Ramon I Klein Geltink; Stylianos Lefkopoulos; Na Yin; Pierre Cauchy; Jonathan D Curtis; Lhéanna Klaeylé; Xavier Langa; Cora C A Beckmann; Marcin W Wlodarski; Patrick Müller; Dominic Van Essen; Angelika Rambold; Friedrich G Kapp; Marina Mione; Joerg M Buescher; Erika L Pearce; Alexander Polyzos; Eirini Trompouki
Journal:  Nat Commun       Date:  2018-08-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.